Moreover, since Sp1 regulates expression of both pro-oncogenic and tumor suppressor-like genes, it has been suggested that “a more complete understanding of the function of Sp1 in cancer is required to validate its potential as a therapeutic target” [17]. This evidence concerns the gene SP1 and cancer.